Citi raised the firm’s price target on Boston Scientific (BSX) to $122 from $107 and keeps a Buy rating on the shares. The company reported ...

BofA raised the firm’s price target on Boston Scientific (BSX) to $115 from $110 and keeps a Buy rating on the shares. The firm notes the ...

Boston Scientific stock jumped Wednesday after the medtech giant easily beat Wall Street's fourth-quarter expectations and its own guidance.

As pulsed field ablation transformed the electrophysiology market over the last year, Boston Scientific Corp. emerged as the ...